Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Samraat Raha — FY2025 total compensation $5,686,740

Samraat Raha is President and Chief Executive Officer of Myriad Genetics Inc (MYGN). The company reported total compensation of $5,686,740 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$856,901
Bonus$0
Stock awards$3,989,729
Option awards$0
Non-equity incentive plan$814,660
Pension and non-qualified deferred compensation$0
All other compensation$25,450
Total$5,686,740

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Myriad Genetics Inc filed April 14, 2026, accession 0000899923-26-000031.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and Chief Executive Officer$856,901$0$3,989,729$0$814,660$0$25,450$5,686,740
FY2024Chief Operating Officer$750,000$0$2,910,681$0$706,500$0$22,146$4,389,327

Totals as disclosed in each year's own compensation disclosure for Myriad Genetics Inc.

03

Peer context

Peer-group chief executive median$8,894,160
Difference from that median$-3,207,419
Percentile within the disclosed peer group15th
Peers with a disclosed figure20

Medians and percentiles are computed across the peer group Myriad Genetics Inc discloses in its own compensation disclosure.

04

The other named executive officers of Myriad Genetics Inc

Named executive officerRoleFY2025 total
Brian DonnellyChief Commercial Officer$6,000,145
Samraat Raha this pagePresident and Chief Executive Officer$5,686,740
Mark VerrattiChief Operating Officer$3,145,251
Scott LefflerFormer Chief Financial Officer$2,736,493
Margaret AnconaFormer EVP, Strategy and Transformation$1,895,166
Dale MuzzeyChief Scientific Officer$1,862,912
Benjamin WheelerChief Financial Officer$1,507,897
Paul DiazFormer President and Chief Executive Officer$688,637

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Myriad Genetics Inc compensation brief.

05

The company page

Samraat Raha's compensation sits inside Myriad Genetics Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Myriad Genetics Inc (MYGN) compensation brief